EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 12 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $991,000 | +1.5% | 100,000 | 0.0% | 0.08% | -1.3% |
| Q2 2022 | $976,000 | -0.9% | 100,000 | 0.0% | 0.08% | -14.3% |
| Q1 2022 | $985,000 | -0.6% | 100,000 | 0.0% | 0.09% | -28.3% |
| Q4 2021 | $991,000 | -0.3% | 100,000 | 0.0% | 0.13% | +0.8% |
| Q3 2021 | $994,000 | -0.5% | 100,000 | 0.0% | 0.13% | +77.5% |
| Q2 2021 | $999,000 | +230.8% | 100,000 | +233.3% | 0.07% | +144.8% |
| Q1 2021 | $302,000 | – | 30,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |